as on January 28, 2026 at 9:42 pm IST
Day's Low
Day's High
2.45%
Downside
1.76%
Upside
52 Week's Low
52 Week's High
58.91%
Downside
17.72%
Upside
Check Protagonist Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.1B
EPS (TTM)
-1.8711
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
3.51%
PE Ratio (TTM)
124.7
Industry PE ratio
5.553333333333334
PEG Ratio
0EBITDA
20.0M
Revenue (TTM)
209.2M
Profit Margin
21.94%
Return On Equity TTM
7.80%
Track how Protagonist Therapeutics Inc P/E has moved over time to understand its valuation trends.
Protagonist Therapeutics Inc in the last 5 years
Lowest (-60.18x)
December 31, 2025
Industry (5.55x)
January 28, 2026
Today (124.70x)
January 28, 2026
Highest (91.67x)
September 30, 2025
Today’s Price to Earnings Ratio: 124.70x
Compare market cap, revenue, PE, and other key metrics of Protagonist Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $5.1B | 290.78% | 124.7 | 21.94% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Protagonist Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Protagonist Therapeutics Inc investment value today
Current value as on today
₹2,21,847
Returns
₹1,21,847
(+121.85%)
Returns from Protagonist Therapeutics Inc Stock
₹1,15,873 (+115.87%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Protagonist Therapeutics Inc. Average target price of $96.33
Get share price movements and forecasts by analysts on Protagonist Therapeutics Inc.
What analysts predicted
14.87%UPSIDE
Target Price
$96.33
Current Price
$82.01
Analyzed by
12 Analysts
Target
$96.33
Protagonist Therapeutics Inc target price $96.33, a slight upside of 14.87% compared to current price of $82.01. According to 12 analysts rating.
Search interest for Protagonist Therapeutics Inc Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 13 October
Mon, 07:35 PM
-Johnson & Johnson reportedly in talks to acquire Protagonist Therapeutics, enhancing their collaboration on immunology treatments.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 year, PTGX stock has moved up by 118.7%
Best in 3 Years
![]()
In the last 3 years, PTGX has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
![]()
In the last 1 year, PTGX has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Protagonist Therapeutics Inc |
| Headquarters | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
| Industry | Health Technology |
| CEO | Dr. Dinesh V. Patel Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Carena Spivey | Senior VP & Chief Human Resources Officer |
Dr. Ashok Bhandari Ph.D. | EVP & Chief Discovery Officer |
Dr. Dinesh V. Patel Ph.D. | CEO, President, Secretary & Director |
Dr. Suneel K. Gupta Ph.D. | Executive Vice President of Clinical Development |
Mr. Mohammad Masjedizadeh Ph.D. | Executive VP & CTO |
Dr. Newman Yeilding | Executive VP, Chief Scientific Officer |
Mr. Asif Ali | Executive VP & CFO |
Dr. Arturo M. Molina FACP, M.D., M.S. | Chief Medical Officer |
Mr. Matthew M. Gosling J.D. | Executive VP and Chief Legal & Business Officer |
Mr. Carter J. King | Executive Vice President of Business Development |
Protagonist Therapeutics Inc share price today is $82.01 as on . Protagonist Therapeutics Inc share today touched a day high of $83.45 and a low of $80.
Protagonist Therapeutics Inc share touched a 52 week high of $96.54 on and a 52 week low of $33.7 on . Protagonist Therapeutics Inc stock price today i.e. is trending at $82.01,which is 15.05% down from its 52 week high and 143.35% up from its 52 week low.
Protagonist Therapeutics Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Protagonist Therapeutics Inc (PTGX) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Protagonist Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Protagonist Therapeutics Inc share’s latest price of $82.01 as on January 28, 2026 at 9:42 pm IST, you will get 0.1219 shares of Protagonist Therapeutics Inc. Learn more about
fractional shares .
Protagonist Therapeutics Inc stock has given 290.78% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?